Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06976736 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Long Term Follow-up Study of TScan TCR-T Products

Study acronym: LTFU
StatusRecruiting
PhaseNot specified
Started2025-09-09
View on ClinicalTrials.gov ↗

Amendment history

2025-09-02
Not Yet Recruiting→Recruiting Study Status, Oversight, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Start date2025-09→2025-09-09
Study sitesdetails revised at 2 of 2 sites
2025-05-13
Original filing
The purpose of this Long-Term Follow-Up (LTFU) study is to monitor participants who have previously received TSC-100 or TSC-101 TCR-T therapies in the TSCAN-001 study. Participants will be monitored for 15 years from the date of TCR-T cell therapy administration to assess long-term safety and efficacy.
Trial Details
NCT Number NCT06976736
Lead Sponsor TScan Therapeutics, Inc.
Conditions AML, ALL, MDS
Enrollment 1,000 participants
Start Date 2025-09-09
Primary Completion 2040-09 (estimated)
Study Completion 2040-09 (estimated)
Updated on ClinicalTrials.gov 2025-09-10